MedPath

Phase I study for the safty of the postoperative urinastatin in patients with resectable lung cancer accompanied with interstitial pneumonitis

Phase 1
Conditions
interstitial pneumonitis lung cancer
Registration Number
JPRN-UMIN000002410
Lead Sponsor
Keio University School of Medicine, division of General Thoracic Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
9
Inclusion Criteria

Not provided

Exclusion Criteria

a)asbestosis b)Patients with interstitial pneumonitis caused by connective tissue disease c)chronic hypersensitivity pneumonitis d)sarcoidosis e)Patients who have the history of allergic reactions against urinastatin f)Patients who are pregnant or have possibility of pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath